NASDAQ: CGBDCarlyle Secured Lending Inc Stock
$13.66-0.08 (-0.58%)
Updated Aug 14, 2025
CGBD Price
$13.66
Fair Value Price
N/A
Market Cap
$995.85M
52 Week Low
$13.12
52 Week High
$18.64
P/E
11.2x
P/B
0.83x
P/S
4.25x
PEG
0.89x
Dividend Yield
9.66%
Revenue
$234.46M
Earnings
$69.65M
Gross Margin
78.6%
Operating Margin
61.41%
Profit Margin
28.6%
Debt to Equity
1.15
Operating Cash Flow
-$133M
Beta
0.62
Next Earnings
N/A
Ex-Dividend
Sep 30, 2025
Next Dividend
Oct 17, 2025
CGBD Overview
TCG BDC, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CGBD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
CGBD
Ranked#64 of 83
Ranked#64 of 83
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.47 | A | |
| $47.14 | A | |
| $145.50 | B |
Be the first to know about important CGBD news, forecast changes, insider trades & much more!
CGBD News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CGBD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CGBD ($13.66) is trading above its intrinsic value of $12.64, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CGBD is good value based on its earnings relative to its share price (11.2x), compared to the US market average (36.29x)
P/E vs Market Valuation
CGBD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CGBD due diligence checks available for Premium users.
Valuation
CGBD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.2x
Industry
49.85x
Market
36.29x
CGBD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CGBD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CGBD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.83x
Industry
3.12x
CGBD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CGBD price to earnings growth (PEG)
For valuing profitable companies with growth potential
CGBD is good value based... subscribe to Premium to read more.
PEG Value Valuation
CGBD's financial health
Profit margin
Revenue
$67.3M
Net Income
$14.6M
Profit Margin
21.7%
CGBD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$1.4B
Debt to equity
1.15
CGBD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CGBD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$230.9M
Investing
$0.0
Financing
$29.3M
CGBD vs Asset Management Stocks
Carlyle Secured Lending Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.